Nebenwirkungen · Myalepta
Myalepta 3 mg powder for solution for injection. Myalepta 5.8 mg powder for solution for injection. Myalepta 11.3 mg powder for solution for injection. · Abschnitt 4.8 · PDF-Seite 10
HOS-136648 · Präparat HOS-097896
Table 7 Adverse reactions reported with Myalepta in > 1 patient during clinical studies in generalised LD and the subgroup of partial LD patients and post-marketing experience System Organ Class Very common Common Frequency not known* Infections and infestations Influenza, Pneumonia Immune system disorders Anaphylactic reaction Metabolism and nutrition Hypoglycaemia Decreased appetite Diabetes mellitus, disorders Hyperphagia, Insulin resistance Nervous system disorders Headache Cardiac disorders Tachycardia Vascular disorders Deep vein thrombosis Respiratory, thoracic and Cough, Dyspnoea mediastinal disorders Pleural effusion Gastrointestinal disorders Abdominal pain, Abdominal pain upper, Nausea Diarrhoea, Pancreatitis, Vomiting Skin and subcutaneous tissue Alopecia Pruritus, Rash, Urticaria disorders Musculoskeletal and Arthralgia, Myalgia connective tissue disorders Reproductive system and Menorrhagia breast disorders
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-10-06T16:51:00Z · SHA-256 8dc700b61702039d2472e9b5c7cadc8ee82ba9cfc98f829db4381f0e7da4f8ef · Passage 2c8265ca2ec13ed55581d84ae95c5bf7cd9d8c9d2a316e914f1f69fdb17c944a · Zeichen 1193–2985 im Abschnitt